FERTIN PHARMA A/S: Financial statements 2015
CVR: 25834844
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 800,654,000 and a net result of DKK 63,953,000 compared with DKK 42,229,000 the year before. That is an increase of 15.4% compared with the year before. The profit margin was 8%. Equity in the 2015 report amounted to DKK 560,874,000. The solvency ratio was 46.2%. The company had 543 employees in the financial year.
- Revenue
- DKK 800,654,000
- Gross Profit
- DKK 467,806,000
- Profit/Loss
- DKK 63,953,000
- Equity
- DKK 560,874,000
- Total Assets
- DKK 1,212,798,000
- Employees
- 543
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 800.7M | 467.8M | 64M | 560.9M | 543 |
| 2014 | 694.1M | 419.5M | 42.2M | 495M | 446 |
Official annual report
How creditworthy is FERTIN PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 17, 2015, Marianne Kock has joined the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2014. Revenue came to DKK 694,057,000, and the net result was DKK 42,229,000.
As of May 11, 2015, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Betina Tandrup Moslund has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Svend Andersen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Erik Bak Mortensen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Henrik Werner Lassen has joined the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Elsebeth Budolfsen has left the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Jane Faltum has left the board of directors of FERTIN PHARMA A/S.
As of May 11, 2015, Ole Dalgaard Mikkelsen has left the board of directors of FERTIN PHARMA A/S.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.